ArticleLeukemia2023

Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study.

Kirsi Manz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.